Es Cushing Localize Resect Ectopic Acth Tumors

---
name: es-cushing-localize-resect-ectopic-acth-tumors
description: This skill recommends localizing and resecting ectopic ACTH-secreting tumors with node dissection when ectopic ACTH secretion is suspected or confirmed. Clinical triggers include unexplained persistent hypercortisolism after pituitary surgery, elevated ACTH with negative pituitary MRI, or identification of occult ectopic ACTH syndrome (EAS) on biochemical testing.
---

# Localizing and Resecting Ectopic ACTH-Secreting Tumors with Node Dissection

## STEP 1 — Gather Information
Confirm biochemical hypercortisolism (elevated UFC or late-night salivary cortisol) and elevated ACTH; obtain pituitary MRI to exclude adenoma; perform inferior petrosal sinus sampling (IPSS) to assess central vs peripheral ACTH source; if peripheral, pursue anatomic imaging (contrast-enhanced CT chest/abdomen/pelvis, somatostatin receptor PET/CT, or Ga-68 DOTATATE) to localize tumor; document size, location, and presence of metastatic nodes.

## STEP 2 — Rule In / Rule Out
Is ectopic ACTH secretion confirmed by peripheral IPSS gradient and/or identification of a tumor on imaging? If yes, proceed to localization and resection planning; if no, reconsider Cushing’s disease or adrenal etiology and repeat biochemical testing or pursue alternative diagnostic pathways.

## STEP 3 — Classify or Stratify
Classify the ectopic ACTH source as occult (no lesion on conventional CT/MRI but positive functional imaging) versus metastatic (radiographically evident lymph node or distant metastases); this determines extent of surgical dissection needed.

## STEP 4 — Decide
For localized occult or resectable metastatic ectopic ACTH tumors, recommend en bloc surgical resection with systematic mediastinal or abdominal lymph node dissection; for unresectable widespread metastasis, consider medical therapy (ketoconazole/metyrapone) or bilateral adrenalectomy as a life-preserving measure while awaiting systemic treatment.

## Clinical Guardrails / Mimics / Pitfalls
Do not rely solely on pituitary MRI; false-negative IPSS can misdirect to pituitary surgery; avoid resection without histologic confirmation when possible; neglecting node dissection increases recurrence risk; proceed to surgery only after multidisciplinary review (endocrinology, thoracic surgery, nuclear medicine); avoid empiric medical therapy without localization in operable disease.

## Concrete Clinical Example
A 48‑year‑old with refractory hypertension, hyperglycemia, and hypokalemia had UFC 3× ULN and ACTH 120 pg/mL; pituitary MRI was negative; IPSS showed peripheral gradient; CT chest revealed a 1.5 cm bronchial carcinoid; video‑assisted thoracoscopic resection with mediastinal lymph node dissection yielded normal postoperative UFC and ACTH; patient remained eucortisolemic at 6‑month follow‑up.

**Source:** Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818